Information Provided By: 
Fly News Breaks for October 10, 2018
CUTR
Oct 10, 2018 | 08:02 EDT
Stephens analyst Chris Cooley said he remains confident Cutera can deliver upon its stated 2021 objectives despite 2018 not unfolding as originally forecast as he believes truSculpt ID offers the potential to more that double the company's current share of the body contouring market by 2021. The analyst, who also thinks Cutera's margins have reached a trough and may favorably inflect exiting this year, sees now as the time to step in and reiterates his Overweight rating and $40 price target on Cutera shares.
News For CUTR From the Last 2 Days
There are no results for your query CUTR
